Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Shumaila Saad"'
Autor:
Tony J. C. Wang, Andrew B. Lassman, Yasir H. Qureshi, Shumaila Saad, Andrew Yaeh, Michael B. Sisti, Steven R. Isaacson, Jeraldine Lesser, Cheng-Chia Wu, Sameer A. Sheth, Keith A. Cauley, Simon K. Cheng, Guy M. McKhann, Tavish Nanda, Jeffrey N. Bruce, Ashish Jani
Publikováno v:
Journal of Neuro-Oncology. 136:281-287
Prior studies of post-operative stereotactic radiosurgery (SRS) have not distinguished between Adjuvant SRS (ARS) versus Adjuvant SRS to residual/recurrent disease (ARD). In this study, we defined ARS and ARD and investigated local control (LC), over
Autor:
Balazs Halmos, Michael R. Snell, Shumaila Saad, J. Philip Kuebler, Nathan A. Pennell, Neelesh Sharma, Afshin Dowlati, Gregory A. Otterson, Shirish M. Gadgeel, Pingfu Fu, Tarek Mekhail
Publikováno v:
The Oncologist. 20:1298-1303
Background. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy is clearly beneficial in patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). However, acquired resistance develops uniformly and the benef
Autor:
Yasir H. Qureshi, Tzlil Rozenblat, Shumaila Saad, Jeffrey N. Bruce, Andrew Yaeh, Guy M. McKhann, Ashish Jani, Andrew B. Lassman, Michael B. Sisti, Tavish Nanda, Steven R. Isaacson, Jeraldine Lesser, Tony J. C. Wang
Publikováno v:
Journal of Neuro-Oncology. 124:507-514
Renal cell carcinoma, sarcoma, and melanoma are considered to be "radioresistant" tumor histologies. Brain metastases (BM) from these tumors are considered unlikely to be controlled using the relatively low doses used in whole brain radiotherapy (WBR
Autor:
Yasir H. Qureshi, Tony J. C. Wang, Jeraldine Lesser, Jeffrey N. Bruce, Ashish Jani, Andrew B. Lassman, Tzlil Rozenblat, Guy M. McKhann, Shumaila Saad, Andrew Yaeh, Tavish Nanda, Michael B. Sisti, Wenzheng Feng, Steven R. Isaacson
Publikováno v:
Neurosurgery. 77:119-125
BACKGROUND The energy index (EI) is a measure of dose homogeneity within a target volume calculated by the integral dose divided by the product of prescription dose and tumor volume. OBJECTIVE To assess whether a higher EI is associated with greater
Autor:
Srinath Kotamarti, Matthew R. Danzig, Michael B. Rothberg, Shumaila Saad, Ruslan Korets, Ketan K. Badani, Jared Levinson, James M. McKiernan
Publikováno v:
Clinical Genitourinary Cancer. 13:239-243
Introduction We examined the effect of non-neoplastic parenchymal volumes (NNPVs) in partial nephrectomy (PN) surgical specimens on long-term postoperative renal function. PN for renal cortical neoplasms has demonstrated superior long-term renal func
Autor:
Michael B. Sisti, Andrew B. Lassman, Tzlil Rozenblat, Yasir H. Qureshi, Shumaila Saad, Tony J. C. Wang, Andrew Yaeh, Jeffrey N. Bruce, Balazs Halmos, Tavish Nanda, Ashish Jani, Steven R. Isaacson, Jeraldine Lesser, Mark B. Stoopler, Guy M. McKhann, Simon K. Cheng
Publikováno v:
Neuro-Oncology. 17:1022-1028
BACKGROUND We investigated effects of genetic alterations in epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and Kirsten rat sarcoma viral oncogene homolog (KRAS) on overall survival (OS) and local control after stereotacti
Autor:
Steven R. Isaacson, K. S. Clifford Chao, Jeraldine Lesser, Ashish Jani, Guy M. McKhann, Shumaila Saad, Yasir H. Qureshi, Jeffrey N. Bruce, Tony J. C. Wang, Simon K. Cheng, Michael B. Sisti, Andrew B. Lassman
Publikováno v:
Journal of Neuro-Oncology. 122:399-408
Optimal treatment of brain metastases (BMs) is debatable. However, surgery or gamma knife radiosurgery (GKRS) improves survival when combined with whole brain radiotherapy (WBRT) versus WBRT alone. We retrospectively reviewed an institutional databas
Publikováno v:
Lung Cancer Management. 3:459-476
SUMMARY The development of EGF receptor (EGFR)-tyrosine kinase inhibitors has recently provided a new therapeutic option for patients with advanced EGFR-mutant NSCLC; however, the long-term efficacy of such therapies is generally limited by the devel
Autor:
Cheng-Chia Wu, Simon K. Cheng, Daniel S. Chow, Timothy H. Ung, Jennifer E. Soun, Heva J. Saadatmand, Juan Estrada, Anurag Saraf, Steven R. Isaacson, Yasir H. Qureshi, Andrew B. Lassman, Matthew D. Garrett, Sameer A. Sheth, Christopher S. Grubb, Guy M. McKhann, Robyn D. Gartrell, Shumaila Saad, Michael B. Sisti, Ashish Jani, Tony J. C. Wang, Jeffrey N. Bruce
Background Studies have shown racial differences in cancer outcomes. We investigate whether survival differences existed in Hispanic patients with glioblastoma (GBM) compared with other ethnicities from our modern radiotherapy series, because no stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31840e38f384c69bf10da229fb53b15
https://escholarship.org/uc/item/75x9m8f9
https://escholarship.org/uc/item/75x9m8f9
Autor:
Shumaila Saad, Edan Y. Shapiro, Gregory W. Hruby, Philippa J. Cheetham, Matthew Truesdale, Aaron E. Katz, Max Pitman
Publikováno v:
The Prostate. 72:1802-1808
BACKGROUND Various definitions of biochemical failure (BF) have been used to predict cancer recurrence following prostate cryoablation. However to date, none of these definitions have been validated for this use. We have reviewed several definitions